Results 121 to 130 of about 7,047 (156)

A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma. [PDF]

Clin Transl Sci
Xu L, Sadanand A, Neczypor EW, Liu YT, Butler E, Moore K, Bowman F, Mazumder Y, Naranjo A, Chlenski A, Xiao X, Guo L, Cohn SL, Applebaum MA, Skapek SX.   +14 more
europepmc   +1 more source

Single-cell and spatial omics reveals region-specific plasticity and therapeutic vulnerabilities in metastatic high-risk neuroblastoma. [PDF]

Sci Adv
Wu LMN, Oblinger JL, Xin D, Rao R, Zhang F, Adam M, Lopez-Nunez O, Szabo S, von Allmen D, Chang LS, Weiss BD, Lu QR.   +11 more
europepmc   +1 more source

Targeting SMC3 deacetylation synergizes with XPO1 inhibition to reprogram the epigenetic landscape and suppress NPM1-mutated acute myeloid leukemia. [PDF]

Nat Commun
Fu J, Xu H, Zhao X, Gao M, Tian Y, Chang Y, Zheng X.   +6 more
europepmc   +1 more source

Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia. [PDF]

Am J Hematol
Ball S, Awan FT, Tomlinson BK, Stopczynski T, Fischer MA, Zhao Z, Fedorov K, Kishtagari A, Mohan SR, Ayers GD, Byrne MT, Savona MR.   +11 more
europepmc   +1 more source

A new therapeutic approach to <i>KRAS</i> mutant non-small cell lung cancer: the emerging role of exportin 1 inhibition. [PDF]

Transl Lung Cancer Res
von Itzstein MS, Gerber DE.
europepmc   +1 more source

Multiple roads between the nucleus and the cytoplasm: classes of linear NLSs and NESs and their receptors. [PDF]

Curr Opin Struct Biol
Wing CE, Chook YM.
europepmc   +1 more source

Erratum: <i>KRAS</i> under attack: recent advances in targeted therapies involving G12C inhibitors and XPO1 inhibition. [PDF]

Transl Lung Cancer Res
Editorial Office.
europepmc   +1 more source

Nuclear export inhibition activates TP53 pathways and is a potent therapeutic strategy in atypical teratoid rhabdoid tumors. [PDF]

Neurooncol Adv
House TO, Alimova I, Larsen S, Murdock G, Pierce A, Brunt B, Tocci S, Krykunenko S, Coppola M, Erdreich-Epstein A, Firestein R, Serkova NJ, Vibhakar R, Tsai JW.   +13 more
europepmc   +1 more source

Selinexor combined with R-CHOP achieved a high response rate in newly diagnosed double/triple-hit lymphoma. [PDF]

Blood Adv
Li C, Chen X, Xu J, Lei T, Yu H, Peng S, Han S, Yang H.   +7 more
europepmc   +1 more source

KPT-330 alleviates osteoarthritis by inhibiting subchondral bone osteoclastogenesis via the NF-κB and MAPK signaling pathways. [PDF]

iScience
Chen W, Liang Y, Liu C, Ling G, Lei S, Huang J, Lin W, Lin C.   +7 more
europepmc   +1 more source